On February 1st, 2025, President Trump issued new tariffs on Canada, Mexico, and China. This added an additional 25% tariff on Canadian and Mexican imports and a 10% tariff on Chinese imports. What ultimately led to the tariffs escalating to a trade war between the U.S. and countries such as China, Canada, and Mexico; however, was the aggressive escalation and retaliation by the Trump administration after the affected countries responded.

Since late 2023, Pakistan has launched a sweeping campaign to expel Afghans labeled as “illegal foreigners.” What began as a crackdown on undocumented residents has expanded to mass deportations of long-settled and registered refugees. By collapsing distinctions between refugees, long-settled residents, and undocumented migrants, Pakistan’s actions undermine the principle of non-refoulement and signal a broader shift away from the norms that have governed regional humanitaria

On September 17, 2025, Texas Governor Greg Abbott signed House Bill 7 into law, targeting access to medication abortion. This legislation joins several existing Texas abortion bans, which are considered the most extreme in the nation, and hopes to inspire similar legislation across the country. HB 7 not only intensifies the reproductive health crisis in Texas, but also has the potential to export that crisis nationwide.

On Sept. 30, 2025, the African Growth and Opportunity Act (AGOA) expired, raising questions about what the future holds for U.S. trade relations with sub-Saharan African nations. Despite its imperfections, the expiration of AGOA represents a significant strategic misstep. A revised Act is essential to supporting sub-Saharan African development and protecting American geopolitical and economic interests.

In the pharmaceutical industry, speed to market is often equated with success. Companies race to advance therapies into human testing to capture the enormous commercial advantages of being first. This “first-mover premium” rewards speed over certainty, particularly in fast-moving fields like oncology and immunotherapy. I propose a regulatory incentive that rewards preclinical validation to address this misalignment with commercial and scientific goals.

On September 29th, 2025, President Trump unveiled a 20-point peace plan known as the Comprehensive Plan to End the Gaza Conflict that, if adhered to by both Israel and Palestine, could possibly end the Israel-Palestine war. Palestinian equality and statehood, one that allows for security, freedom, and economic prosperity, must be recognized in full if peace in the Middle East is finally to be established again.